One of the advantages of the 13С urea breath test is that is requires no endoscope; all that is needed is the air exhaled by the patient.
Nowadays, H. pylori bacteria, one of the prevalent human infections has, been proved to be the root cause of gastritis, stomach and duodenal bulb ulcer and oncologic stomach pathologies.
The bacteria causes an inflammation of the stomach lining and stimulates hydrochloric acid generation which may result in the development of erosions and ulcers, and, in the presence of a chronic inflammation, cause an atrophy and subsequent development of stomach cancer.
What are the routes of infection?
The H. pylori infection is transmitted from person to person. These bacteria are anaerobic, that is, they die in the open air, and are transmitted in saliva and mucus. Infection often occurs in families or other close groups since the infection is transmitted through the use of the same utensils, due to nonobservance of hygiene standards or in crowded environments. The infection is frequently transmitted from mother to child. One may contract the infection even through a kiss.
INDICATIONS TO 13С UREA BREATH TEST
- Any manifestations of digestive problems (frequent occurrences of acid stomach or belching, painful sensations in the stomach after eating, nausea and sudden signs of metabolic disorders);
- prophylaxis of oncology diseases of the digestive tract;
The key efforts in oncopathology prevention are directed toward earliest possible discovery of Helicobacter pylori infection and performance of anti-helicobacter (eradication) therapy.
HOW CAN HELICOBACTER PYLORI BE DETECTED NON-INVASIVELY?
The most advanced diagnosis method is 13С urea breath test whose main advantage is that it requires no endoscope; all that is needed is the air exhaled by the patient!
The test’s sensitivity and specificity is 92 to 95%.
There are no contraindications to the performance of 13С urea breath test.
PREPARING FOR THE BREATH TEST
- The patient should take no food less than six hours before the test;
- the test should not be performed earlier than 24 hours after an esophagogastroduodenoscopy examination;
- the test should be performed no sooner than four to six weeks after the administration of antibiotics (for any reason) and/or bismuth-based pharmaceuticals (Denol, Ulkavis, etc.);
- the test shall be performed no sooner than two weeks after the completion of administration of proton pump inhibiting pharmaceuticals (Omeprazol, Omez, Nolpaza, Pantap, Pantasan, Controloc, Pantoprazol, Emanera, Ezocar, Lansoprazol, etc.);
- the patient should take non-steroidal anti-inflammatory pharmaceuticals no sooner than five days before the examination;
- the patient should not smoke or chew gum immediately before the procedure.
The above measures should prevent false-negative test results.
HOW CAN I GET THIS TEST AT THE RCMC
- Please call the Contact Center and book an appointment for the examination
- You need to complete and sign a paid service contract at the Reception (present a physician's referral to the receptionist)
- Pay the bill at the RCMC pay office, or through the ERIP electronic system
- Get the test at the appointed time.